Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-17 Sale |
2025-02-27 4:01 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
15,093 | $14.84 | $223,965 | 237,638 (Direct) |
View |
| 2023-11-03 Sale |
2023-11-14 8:59 pm |
Tabula Rasa HealthCare Inc. | TRHC | Schwartz Jonathan David Director |
78,388 | $0 | $0 | 0 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-22 7:28 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
3,557 | $19.06 | $67,796 | 94,546 (Direct) |
View |
| 2022-03-30 Sale(A) |
2022-04-04 07:37 am |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
135,000 | $16.21 | $2,187,740 | 89,529 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 4:51 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
45,000 | $16.41 | $738,652 | 179,529 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Option Award |
2025-02-13 4:01 pm |
N/A 2025-02-11 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
200,000 | $0 | 372,413 (Direct) |
View |
Ownership |
2024-04-03 6:07 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
0 | $0 | 717,192 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 4:33 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Schwartz Jonathan David Director |
25,641 | $0 | 78,388 (Direct) |
View |
| 2023-02-14 Exercise(A) |
2023-02-22 7:25 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
8,574 | $0 | 281,550 (Direct) |
View |
| 2023-02-14 Option Award(A) |
2023-02-22 7:25 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
166,037 | $0 | 281,550 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 4:45 pm |
N/A 2033-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
166,037 | $0 | 166,037 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 9:06 pm |
N/A N/A |
Tabula Rasa HealthCare Inc. | TRHC | Schwartz Jonathan David Director |
52,747 | $0 | 52,747 (Direct) |
View |
| 2022-08-12 Option Award |
2022-08-16 5:33 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
22,896 | $0 | 22,896 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-16 9:02 pm |
N/A 2032-02-13 |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks |
106,994 | $0 | 106,994 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David Chief Medical Officer |
11,428 | $1.69 | 262,838 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David Chief Medical Officer |
213,101 | $1.21 | 262,838 (Direct) |
View |